Skip to main content

NJ Ethicon Hernia Mesh Lawsuits Might Get MCL Status

NJ Ethicon Hernia Mesh Lawsuits Might Get MCL Status

NJ Ethicon Hernia Mesh Lawsuits Might Get MCL Status

Introduction

The reports of early failure and complications resulting in the need for hernia revision surgery involving Ethicon Hernia Mesh lead to the filing of hundreds of lawsuits by people across the nation against Johnson & Johnson and its Ethicon subsidiary. The product was recalled from the market worldwide in May 2016.

With the mounting number of similar claims in New Jersey, a request for a multicounty litigation (MCL) has been put before New Jersey Supreme Court, which if established would help in avoiding the need for individual trials and in managing the growing number of cases in the state.

In June 2017, MDL No.2782 (In re Ethicon Physiomesh Flexible composite Hernia Mesh Products Liability Litigation) was established to centralize hundreds of complaints filed against the hernia mesh defendants Johnson & Johnson and its Ethicon subsidiary involving Ethicon Physiomesh lawsuits for coordinated pretrial proceedings. The first trials are scheduled to begin in September 2019.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!